A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE)

NCT05035082 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1020

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: semaglutide
DRUG: oral glucose-lowering medications (commercially available)

Sponsor

Novo Nordisk A/S